HPV Elimination – Let’s not let inequity stand in our way
Nelly Mugo, MBChB, MMed, MPH
Research Associate Professor, Global Health
Prof. Nelly R. Mugo is an associate research professor in the Department of Global Health at the University of Washington, a senior principal clinical research scientist at the Kenya Medical Research Institute (KEMRI), and a reproductive health specialist with three decades of work experience. Her research focus has been on the prevention of HIV and cervical cancer among other reproductive health research work. She has been an investigator on two landmark clinical trials, the Partners PrEP study that contributed evidence to inform the change of indication for use of Truvada as HIV prevention pre-exposure prophylaxis (PrEP) and a protocol lead for the ongoing ‘Kenya Single-dose HPV Vaccine-Efficacy (KEN SHE) Study –’ that has provided evidence on the efficacy of single-dose HPV vaccination. She is a member of the International Papillomavirus Society education committee, and the Kenya Obstetrics and Genecology society and has contributed to several World Health Organization and Kenya ministry of health working group scientific committees. She is widely published in peer review journals.
InSTI Switch During Menopause is Associated with Accelerated Body Composition Change
Rebecca Abelman, MD
Clinical Instructor, Division of HIV, Infectious Diseases, and Global Medicine
Dr. Rebecca Abelman is an infectious disease physician, HIV primary care provider, and Clinical Instructor in the Division of HIV, Infectious Diseases, and Global Medicine at Zuckerberg San Francisco General Hospital at the University of California, San Francisco. Her research interest is in the progression of aging-related comorbidities among women with HIV across the reproductive lifespan, with a particular interest in cardiometabolic and pulmonary disease. She works at the intersection of reproductive aging and clinical outcomes among women with HIV both domestically, leveraging the MWCCS, as well as in Kampala, Uganda.